Most bought healthcare stocks in Q4 2023
See which Healthcare stocks institutional investors increased the most in Q4 2023, measured as net growth in reported share positions from Q3 2023 into Q4 2023. Notable additions at the top of this list include BAXTER INTERNATIONAL INC (BAX), AVANTOR INC (AVTR), RECURSION PHARMACEUTICALS-A (RXRX), ZIMMER BIOMET HOLDINGS INC (ZBH). These rankings aggregate SEC 13F filings from all institutional investors in our database.
Explore more:
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| BAX | BAXTER INTERNATIONAL INC | 36,136,398 | $1.41B | 0 | 7 | 3 | 1 | 13 |
| AVTR | AVANTOR INC | 35,023,526 | $1.05B | 0 | 4 | 1 | 2 | 8 |
| RXRX | RECURSION PHARMACEUTICALS-A | 13,802,950 | $151.29M | 1 | 1 | 0 | 0 | 2 |
| ZBH | ZIMMER BIOMET HOLDINGS INC | 6,879,509 | $892.81M | 0 | 8 | 4 | 0 | 13 |
| LFST | LIFESTANCE HEALTH GROUP INC | 6,001,312 | $49.57M | 0 | 1 | 0 | 1 | 1 |
| CVS | CVS HEALTH CORP | 5,264,762 | $643.57M | 4 | 7 | 8 | 1 | 21 |
| PACB | PACIFIC BIOSCIENCES OF CALIF | 4,355,211 | $89.47M | 0 | 1 | 0 | 1 | 2 |
| VTRS | VIATRIS INC | 3,435,728 | $39.82M | 2 | 1 | 3 | 0 | 9 |
| GEHC | GE HEALTHCARE TECHNOLOGY | 3,091,458 | $425.62M | 1 | 3 | 6 | 1 | 14 |
| BMY | BRISTOL-MYERS SQUIBB CO | 2,992,421 | -$94.55M | 2 | 10 | 4 | 1 | 20 |
| NVST | ENVISTA HOLDINGS CORP | 2,797,727 | $21.20M | 0 | 2 | 1 | 0 | 3 |
| DOCS | DOXIMITY INC-CLASS A | 2,251,920 | $56.62M | 2 | 2 | 1 | 0 | 5 |
| BLUE | BLUEBIRD BIO INC | 2,210,201 | -$238.00K | 1 | 2 | 0 | 0 | 3 |
| NVRO | NEVRO CORP | 2,197,547 | $46.66M | 1 | 1 | 0 | 0 | 2 |
| CLOV | CLOVER HEALTH INVESTMENTS CO | 2,178,578 | -$451 | 0 | 1 | 0 | 1 | 2 |
| VERV | VERVE THERAPEUTICS INC | 1,989,116 | $28.97M | 1 | 1 | 0 | 0 | 2 |
| NKTR | NEKTAR THERAPEUTICS | 1,818,794 | -$25 | 0 | 1 | 0 | 0 | 2 |
| HLN | HALEON PLC-ADR | 1,804,981 | -$2.00M | 0 | 4 | 2 | 0 | 9 |
| RCM | R1 RCM INC | 1,799,098 | $19.02K | 1 | 0 | 0 | 0 | 1 |
| AKBA | AKEBIA THERAPEUTICS INC | 1,623,956 | $2.33K | 0 | 1 | 0 | 0 | 1 |
| HRTX | HERON THERAPEUTICS INC | 1,592,000 | $2.90K | 0 | 1 | 0 | 0 | 1 |
| ABT | ABBOTT LABORATORIES | 1,574,817 | $402.89M | 3 | 6 | 5 | 1 | 21 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 1,563,251 | $161.20M | 2 | 2 | 2 | 0 | 6 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 1,553,135 | $9.08K | 0 | 1 | 0 | 0 | 1 |
| NTLA | INTELLIA THERAPEUTICS INC | 1,477,289 | $33.39M | 1 | 2 | 0 | 0 | 3 |
| JNJ | JOHNSON & JOHNSON | 1,453,037 | -$15.90M | 4 | 11 | 10 | 2 | 30 |
| DXCM | DEXCOM INC | 1,408,407 | $197.58M | 3 | 3 | 2 | 1 | 8 |
| ESPR | ESPERION THERAPEUTICS INC | 1,363,944 | $452.54K | 1 | 1 | 0 | 0 | 2 |
| TDOC | TELADOC HEALTH INC | 1,350,989 | $81.92M | 0 | 5 | 0 | 0 | 6 |
| BSX | BOSTON SCIENTIFIC CORP | 1,302,223 | $87.79M | 2 | 5 | 2 | 0 | 9 |
| ERAS | ERASCA INC | 1,266,400 | $2.82K | 0 | 1 | 0 | 0 | 1 |
| ADPT | ADAPTIVE BIOTECHNOLOGIES | 1,246,005 | -$16.47M | 0 | 1 | 0 | 1 | 2 |
| PSNL | PERSONALIS INC | 1,240,454 | $7.09M | 0 | 2 | 0 | 0 | 2 |
| KPTI | KARYOPHARM THERAPEUTICS INC | 1,233,977 | $720 | 0 | 1 | 0 | 0 | 1 |
| EW | EDWARDS LIFESCIENCES CORP | 1,197,763 | $139.03M | 2 | 5 | 2 | 2 | 10 |
| ACRS | ACLARIS THERAPEUTICS INC | 1,113,180 | $12.52K | 1 | 1 | 0 | 0 | 2 |
| NUVB | NUVATION BIO INC | 1,093,131 | $655.62K | 0 | 1 | 0 | 0 | 3 |
| TVTX | TRAVERE THERAPEUTICS INC | 1,086,892 | $9.87K | 0 | 1 | 0 | 0 | 1 |
| BFLY | BUTTERFLY NETWORK INC | 1,076,184 | -$147.10K | 0 | 4 | 0 | 0 | 4 |
| QSI | QUANTUM-SI INC | 1,074,905 | $7.22M | 0 | 2 | 0 | 0 | 2 |
| TXG | 10X GENOMICS INC-CLASS A | 1,044,242 | $102.55M | 0 | 1 | 1 | 0 | 3 |
| VEEV | VEEVA SYSTEMS INC-CLASS A | 1,020,194 | $135.98M | 4 | 6 | 1 | 1 | 13 |
| GOSS | GOSSAMER BIO INC | 1,007,001 | $14.70K | 1 | 1 | 0 | 0 | 2 |
| BKD | BROOKDALE SENIOR LIVING INC | 966,993 | $2.56M | 0 | 2 | 0 | 0 | 2 |
| CDNA | CAREDX INC | 957,217 | $46.13M | 0 | 3 | 0 | 0 | 3 |
| HCA | HCA HEALTHCARE INC | 953,163 | $398.74M | 4 | 3 | 3 | 1 | 10 |
| MCK | MCKESSON CORP | 932,230 | $506.65M | 4 | 4 | 3 | 1 | 11 |
| OGN | ORGANON & CO | 917,948 | $2.59M | 1 | 2 | 1 | 3 | 6 |
| SENS | SENSEONICS HOLDINGS INC | 912,100 | $520 | 1 | 0 | 0 | 0 | 1 |
| IRWD | IRONWOOD PHARMACEUTICALS INC | 886,636 | $2.53M | 0 | 2 | 0 | 0 | 2 |
Frequently asked questions about Most bought healthcare stocks in Q4 2023
What are the most bought Healthcare stocks in Q4 2023?
The most bought healthcare stocks in Q4 2023 are those with the largest increase in reported share counts across institutional investors compared to Q3 2023, based on SEC 13F filings.
Which healthcare stocks did institutional investors added to the most in Q4 2023?
Among filers in this sector, net additions were largest in companies such as BAXTER INTERNATIONAL INC (BAX), AVANTOR INC (AVTR), RECURSION PHARMACEUTICALS-A (RXRX), based on aggregated 13F data.
How is institutional buying calculated?
Buying is calculated by summing the net increase in shares reported by institutional investors between two consecutive quarterly 13F snapshots (compared to Q3 2023).
Does this include all institutional owners?
Yes. These rankings aggregate SEC 13F filings from all institutional investors in our database, not only the investors we track individually.
Are these trades real-time?
No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.